What Pfizer Inc (NYSE:PFE), Intel Corporation (NASDAQ:INTC), & Gilead Sciences (NASDAQ:GILD) Have In Common
Pfizer (NYSE:PFE) & Intel Corporation (NASDAQ:INTC) paid big bucks for growth, but Mobileye NV (NYSE:MBLY) is a bet on innovation.
Gilead Sciences Inc does not need to acquire for GILD stock to reverse course and trade higher. Brian & Liam take two angles on Gilead stock.
Gilead Sciences’ guidance was horrible, & GILD stock should be down 15%. There’s a good reason it only fell 5%, and why Gilead stock will recover.
GILD stock does not support Gilead Sciences’ HCV franchise, its $31 billion in cash, and significantly undervalues its HIV franchise.
GILD stock, AMGN stock, GOOGL stock, & IBM stock may not gain much from a reduction in the corporate tax rate, but not all are bad investments.
Why ACAD stock will be the next Medivation. Pfizer, Gilead, Teva, Bristol-Myers, Otsuka & AbbVie are all companies that would want Nuplazid & Acadia Pharma